MACTER financials Macter International Limited
Macter International Limited (MACTER) has 13 financial years on file, from the year to 30 Jun 2013. The latest, the year to 30 Jun 2026 earned Rs 15.24 a share on sales of Rs 11.7 bn. 5 quarters are listed below the years.
Results by financial year
Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 30 June. 5 years and 5 of the last 8 quarters.
Earnings per share by financial year
| Year | Earnings per share (Rs) | Sales | Gross margin | Net profit as a share of sales | Change in earnings per share on the year before |
|---|---|---|---|---|---|
| Year to 30 Jun 2026 | 15.24 | Rs 11.7 bn | 48.3% | 6.0% | -5.3% |
| Year to 30 Jun 2025 | 16.10 | Rs 9.9 bn | 45.0% | 7.4% | +72.7% |
| Year to 30 Jun 2024 | 9.32 | Rs 7.5 bn | 42.2% | 5.7% | +8.6% |
| Year to 30 Jun 2023 | 8.58 | Rs 6.7 bn | 41.7% | 5.9% | +19.3% |
| Year to 30 Jun 2022 | 7.19 | Rs 5.3 bn | 44.7% | 6.0% | — |
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 2.16 | Rs 3.1 bn | Rs 99.1 m | 3.2% | -36.7% |
| Quarter to 31 Mar 2026 | 2.00 | Rs 2.8 bn | Rs 91.8 m | 3.3% | -3.4% |
| Quarter to 31 Dec 2025 | 5.91 | Rs 3.3 bn | Rs 270.9 m | 8.1% | — |
| Quarter to 30 Sep 2025 | 3.41 | Rs 2.8 bn | Rs 156.2 m | 5.6% | — |
| Quarter to 31 Mar 2025 | 2.07 | Rs 2.4 bn | Rs 94.9 m | 3.9% | — |
Annual report figures: income and balance sheet
From each annual report. A blank is a line this page does not show for that year.
| Year | Revenue | Gross profit | Profit after tax | Total assets | Equity | Liabilities | Return on equity | Current ratio | Basis |
|---|---|---|---|---|---|---|---|---|---|
| Year to 30 Jun 2026 | Rs 11.7 bn | Rs 5.7 bn | Rs 698.0 m | Rs 8.0 bn | Rs 4.4 bn | Rs 3.5 bn | 15.8% | 1.84 | unknown |
| Year to 30 Jun 2025 | Rs 9.9 bn | Rs 4.5 bn | Rs 738.0 m | Rs 6.6 bn | Rs 3.8 bn | Rs 2.8 bn | 19.4% | 1.92 | unknown |
| Year to 30 Jun 2024 | Rs 7.5 bn | Rs 3.2 bn | Rs 427.0 m | Rs 5.4 bn | Rs 3.2 bn | Rs 2.2 bn | 13.4% | 1.90 | unknown |
| Year to 30 Jun 2023 | Rs 6.7 bn | Rs 2.8 bn | Rs 393.0 m | Rs 4.9 bn | Rs 2.9 bn | Rs 2.1 bn | 13.7% | 1.76 | unknown |
| Year to 30 Jun 2022 | Rs 5.3 bn | Rs 2.4 bn | Rs 318.0 m | Rs 4.4 bn | Rs 2.6 bn | Rs 1.9 bn | 12.4% | 1.71 | unknown |
| Year to 30 Jun 2020 | Rs 5.5 bn | Rs 2.0 bn | Rs 15.0 m | Rs 4.0 bn | Rs 1.2 bn | Rs 2.8 bn | 1.3% | 1.14 | unknown |
| Year to 30 Jun 2019 | Rs 4.1 bn | Rs 1.7 bn | Rs 106.0 m | Rs 3.2 bn | Rs 1.2 bn | Rs 2.0 bn | 8.9% | 1.15 | unknown |
| Year to 30 Jun 2018 | Rs 4.1 bn | Rs 1.8 bn | Rs 246.0 m | Rs 3.0 bn | Rs 1.2 bn | Rs 1.9 bn | 21.1% | 1.24 | unknown |
| Year to 30 Jun 2017 | Rs 3.6 bn | Rs 1.7 bn | Rs 274.0 m | Rs 2.7 bn | Rs 1.1 bn | Rs 1.6 bn | 24.0% | 1.34 | unknown |
| Year to 30 Jun 2016 | Rs 3.1 bn | Rs 1.3 bn | Rs 147.0 m | Rs 2.4 bn | Rs 984.0 m | Rs 1.4 bn | 14.9% | 1.37 | unknown |
| Year to 30 Jun 2015 | Rs 2.4 bn | Rs 846.0 m | Rs 19.0 m | Rs 2.1 bn | Rs 868.0 m | Rs 1.3 bn | 2.2% | 1.30 | unknown |
| Year to 30 Jun 2014 | Rs 2.6 bn | Rs 959.0 m | Rs 100.0 m | Rs 2.1 bn | Rs 917.0 m | Rs 1.2 bn | 10.9% | 1.38 | unknown |
| Year to 30 Jun 2013 | Rs 2.2 bn | Rs 965.0 m | Rs 175.0 m | Rs 1.8 bn | Rs 840.0 m | Rs 925.0 m | 20.8% | 1.37 | unknown |
Source: annual report, page 34.
Ratios from the latest annual report
- Return on equity
- 15.8%
- Return on assets
- 8.8%
- Book value a share
- Rs 96.33
- Price to book value
- 2.74 times
- Current ratio
- 1.84
- Debt to equity
- 0.80
- Equity as a share of assets
- 55.4%
- Gross margin
- 48.2%
- Operating margin
- 11.8%
- Tax rate paid
- 44.2%
As of 30 Jun 2026.
More on MACTER
- MACTER share price and overview
- MACTER dividend history
- Pharmaceuticals sector
- OTSU financials · Otsuka Pakistan Limited
- SAPL financials · Sanofi-Aventis Pakistan Limited
- SEARL financials · The Searle Company Limited
- GLAXO financials · GlaxoSmithKline Pakistan Limited
- ABOT financials · Abbott Laboratories (Pakistan) Limited
- HALEON financials · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .